Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,857 papers from all fields of science
Search
Sign In
Create Free Account
AVN 944
Known as:
AVN-944
, AVN944
An orally available, synthetic small molecule with potential antineoplastic activity. AVN944 inhibits inosine monosphosphate dehydrogenase (IMPDH…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Carbamates
Phenylurea Compounds
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Evaluation of Short Term Effects of Hyperbaric Oxygen and Enoxaparin Treatments in Avascular Necrosis of Femoral Head
Abdullah Arslan
,
F. Dikici
,
S. Purisa
,
N. Olgaç
,
S. Aydın
Selçuk tıp dergisi
2019
Corpus ID: 145907079
OZET Amac: Femur basi avaskuler nekrozu (AVN), femur basini besleyen damarlarin hasarlanmasi veya tikanmasi sonucu ortaya…
Expand
2018
2018
Laboratory varietal control as a guarantee of successful work of agribusiness in Russia
A. Lyubimova
,
D. Eremin
2018
Corpus ID: 73650463
A new direction of agribusiness has been formed in the modern agricultural industry. This is expressed in the appearance of…
Expand
2017
2017
Gelişimsel kalça displazisinde avasküler nekroz: Preoperatif ve postoperatif değerlendirme
Serkan Sipahioğlu
,
Baran Sarikaya
,
Celal Bozkurt
,
H. Askar
,
Uğur Erdem Işıkan
2017
Corpus ID: 188360563
Amac: Salter pelvik osteotomisi ile tedavi edilmis gelisimsel kalca displazisi hastalarinin sonuclari ameliyat oncesi ve sonrasi…
Expand
2013
2013
이미지복잡도 측정 기술을 활용한 사용자 인터페이스의 시각복잡도 평가
김헌
,
임종혁
,
+5 authors
손지택
IFIP TC13 International Conference on Human…
2013
Corpus ID: 75054261
운전 중 자동차 AVN (Audio, Video, Navigation…
Expand
2008
2008
GTP as a biomarker of inosine monophosphate dehydrogenase (IMPDH) inhibition, in patients with advanced hematological malignancies treated with AVN944 in a phase I trial
Karina M. Zuck
,
M. Choe
,
K. Strand
,
J. Strovel
,
J. Hamilton
,
D. Bol
2008
Corpus ID: 53811780
14515 Background: AVN944 is an inhibitor of inosine monophosphate dehydrogenase (IMPDH), an enzyme that catalyzes the rate…
Expand
2007
2007
Antiangiogenic properties of the IMPDH inhibitor AVN944
Z. Weaver
,
J. Strovel
,
M. Chakiath
,
P. Natarajan
,
T. Lawrence
,
D. Bol
2007
Corpus ID: 90517782
3983 AVN944 is an orally bioavailable inhibitor of inosine monophosphate dehydrogenase 1 and 2 (IMPDH). IMPDH2 is the rate…
Expand
2007
2007
Clinical-Biomarker Correlations in Adult AML Patients in a Phase I Trial of AVN944 Support Observations of Clinical Effect and Provide Hypotheses for Patient Selection Criteria for Further Clinical…
R. Klisovic
,
S. Coutre
,
+7 authors
B. Mitchell
2007
Corpus ID: 79102737
Background: AVN944 is an uncompetitive inhibitor of inosine monophosphate dehydrogenase (IMPDH) that catalyzes the rate limiting…
Expand
2007
2007
A phase I trial of AVN944 in patients with advanced hematologic malignancies
R. Klisovic
,
G. Tricot
,
+7 authors
B. Mitchell
2007
Corpus ID: 74715407
14026 Background: AVN-944 is an inhibitor of inosine monophosphate dehydrogenase (IMPDH), an enzyme that catalyzes the rate…
Expand
2000
2000
Atrioventricular Nodal versus Atrioventricular Supraventricular Reentrant Tachycardias: Characterization by an Integrated Doppler Electro‐physiological Hemodynamic Study
D. Mele
,
P. Alboni
,
G. Fucà
,
S. Scarfò
,
N. Paparella
,
R. Levine
Pacing and clinical electrophysiology : PACE
2000
Corpus ID: 42735362
During reentrant Supraventricular tachycardias involving the atrioventricular node (A VN‐SVT) or an A V bypass tract (AV‐SVT…
Expand
1962
1962
Die Rolle des Auxins bei der Epinastischen Krümmung plagiotroper Seitensprosse vonColeus Blumei Benth
Heinz Leike
,
H. Guttenberg
Planta
1962
Corpus ID: 40145963
I. Einleitung Schon ])~ VRI~S (1871) kam zu der Auffassung, daft es sich beim Plagiotropismus um ein Gleichgewieht zwischen zwei…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE